Beam Therapeutics Inc (BEAM)
23.43
-0.55
(-2.29%)
USD |
NASDAQ |
Jun 28, 16:00
23.50
+0.07
(+0.30%)
After-Hours: 20:00
Beam Therapeutics Revenue (Annual): 377.71M for Dec. 31, 2023
Revenue (Annual) Chart
Historical Revenue (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 377.71M |
| December 31, 2022 | 60.92M |
| December 31, 2021 | 51.84M |
| Date | Value |
|---|---|
| December 31, 2020 | 0.024M |
| December 31, 2019 | 0.018M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Annual) Range, Past 5 Years
0.018M
Minimum
2019
377.71M
Maximum
2023
98.10M
Average
51.84M
Median
2021
Revenue (Annual) Benchmarks
| Iovance Biotherapeutics Inc | 1.189M |
| Revolution Medicines Inc | 11.58M |
| Day One Biopharmaceuticals Inc | -- |
| Perspective Therapeutics Inc | -- |
| Electromed Inc | 48.07M |